Barclays »

Zentalis Pharmaceuticals shares owned by Barclays

Quarter-by-quarter ownership of Zentalis Pharmaceuticals (ZNTL) shares owned by Barclays from 13F filings

Historical chart of Barclays investment in Zentalis Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Zentalis Pharmaceuticals held by Barclays consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Zentalis Pharmaceuticals by Barclays

Quarter filed Position value Share count Share price at filing
2024-03-31 $1.0M 66k 15.76
2023-12-31 $3.3M 220k 15.15
2023-09-30 $2.2M 111k 20.06
2023-06-30 $6.0M 212k 28.21
2023-03-31 $1.5M 90k 17.19
2022-12-31 $2.6M 128k 20.14
2022-09-30 $2.5M 117k 21.66
2022-06-30 $96k 3.4k 27.99
2022-03-31 $316k 6.9k 46.13